Increased expression of fascin associated with malignant transformation of sinonasal inverted papilloma

Chinese Medical Journal

Volumn 120, Issue 5, 2007, Pages 375-379

  Wang, An Liu ^a,b   Liu, Hong Gang ^a   Zhang, Yong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Dysplasia; Fascin; Malignancy; Sinonasal inverted papilloma

Indexed keywords

FASCIN; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CARCINOGENESIS; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVERTED PAPILLOMA; MALE; MALIGNANT TRANSFORMATION; PARANASAL SINUS TUMOR; PATHOPHYSIOLOGY; PRECANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCORING SYSTEM;

EID: 33947648069     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200703010-00005     Document Type: Article

References (30)

1. Shanmugaratnam Y, Sobin LH. Histological typing of tumours of the upper respiratory tract and ear. Berlin: Springer Verlag; 1991: 20-21.
2. Barnes L, Eveson J W, Reichart P, Sidransky D. Pathology and genetics of head and neck tumours. Lyon: IARCP Press; 2005: 28-30.
3. Hyams VJ. Papillomas of the nasal cavity and paranasal sinuses: a clinicopathological study of 315 cases. Ann Otol Rhinol Laryngol 1971; 80: 192-206.
4. Kureishy N, Sapountzi V, Prag S, Anilkumar N, Adams JC. Fascins, and their roles in cell structure and function. Bioessays 2002; 24: 350-361.
5. Pelosi G, Pastorino U, Pasini F, Maissoneuve P, Fraggetta F, Iannucci A. Independent prognostic value of fascin immunoreactivity in stage I non-small cell lung cancer. Br J Cancer 2003; 88: 537-547.
6. Pelosi G, Pasini F, Fraggetta F, Pastorino U, Iannucci A, Maisonneuve P. Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids. Lung Cancer 2003; 42: 203-213.
7. Grothey A, Hashizume R, Sabin AA, McCrea PD. Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer. Br J Cancer 2000; 83: 870-873.
8. Grothey A, Hashizume R, Ji H, Tubb BE, Patrick CW Jr, Yu D. C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines. Oncogene 2000; 19: 4864-4875.
9. Jawhari AU, Buda A, Jenkins M, Shebzad K, Sarraf C, Noda M. Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol 2003; 162: 69-80.
10. Maitra A, Adsay NV, Argani P, Iacobuzio-Donahue C, De Marzo A, Cameron JL. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol 2003; 16: 902-912.
11. Maitra A, Iaobuzio-Donahue C, Rahman A, Sohn TA, Argani P, Meyer R. Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47. Am J Clin Pathol 2002; 118: 52-59.
12. Swierczynski SL, Maitra A, Abraham SC, Iacobuzio-Donahue CA, Ashfaq R, Cameron JL. Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays. Hum Pathol 2004; 35: 357-366.
13. Hu W, McCrea PD, Deavers M, Kavanagh JJ, Kudelka AP, Verschraegen CF. Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors. Clin Exp Metastasis 2000; 18: 83-88.
14. Goncharak VN, Ross JS, Carlson JA. Actin binding protein fascin expression in skin neoplasia. J Cutan Pathol 2002; 29: 430-438.
15. Zhang H, Xu L, Xiao D, Xie J, Zeng H, Cai W. Fascin is a potential biomarker for early-stage esophageal squamous cell carcinoma. J Clin Pathol 2006; 59: 958-964.
16. Kabukcuoglu S, Ozalp SS, Oner U, Acikalin MF, Yalcin OT, Colak E. Fascin, an actin-bundling protein expression in cervical neoplasms. Eur J Gynaecol Oncol 2005; 26: 636-641.
17. Tong GX, Yee H, Chiriboga L, Hernandez O, Waisman J. Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder. Hum Pathol 2005; 36: 741-746.
18. Hashimoto Y, Shimada Y, Kawamura J, Yamasaki S, Imamura M. The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 2004; 67: 262-270.
19. Myers EN, Fernau JL, Johnson JT, Tabet JC, Barnes EL. Management of inverted papilloma. Laryngoscope 1990; 100: 481-490.
20. Lawson W, Ho B, Shaari CM, Biller HF. Inverted papilloma: a report of 112 cases. Laryngoscope 1995; 105: 282-288.
21. Aznavoorian S, Murphy AN, Stetler-Stevenson WG, Liotta LA: Molecular aspects of tumor cell invasion and metastasis. Cancer 1993; 71: 1368-1383.
22. Partin AW, Schoeniger JS, Mohler JL, Coffey DS. Fourier analysis of cell motility: Correlation of motility with metastatic potential. Proc Natl Acad Sci USA 1989; 86: 1254-1258.
23. Liotta LA, Kohn EC. The microenvironment of the tumor-host interface. Nature 2001; 411: 375-379.
24. Otto JJ. Actin-bundling protein. Curr Opin Cell Biol 1994; 6: 105-109.
25. Tilney LG, Connelly PS, Vranich KA, Shaw MK, Guild GM. Why are two different cross-linkers necessary for actin bundle formation in vivo and what does each cross-link contribute? J Cell Biol 1998; 143: 121-133.
26. Matsudaira P. Actin crosslinking proteins at the leading edge. Semin Cell Biol 1994; 5: 165-174.
27. Adams JC. Fascin protrusions in cell interactions. Trends Cardiovasc Med 2004; 14: 221-226.
28. Adams JC. Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol 2004; 16: 590-596.
29. Yoder BJ, Tso E, Skacel M, Pettay J, Tarr S, Budd T. The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. Clin Cancer Res 2005; 11: 186-192.
30. Hashimoto Y, Ito T, Inoue H, Okumura T, Tanaka E, Tsunoda S. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin Cancer Res 2005; 11: 2597-2605.